El interés en corto de US Treasury 10 Year Note ETF da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de US Treasury 10 Year Note ETF. Los datos de interés en corto se actualizan cada dos semanas.

US Treasury 10 Year Note ETF (NASDAQ:UTEN), Informe de interés en corto

The Fund is a passively-managed exchange-traded fund that seeks investment results, before fees and expenses, that correspond generally to the price and yield performance of the Bloomberg US Treasury Bellwether 10Y Total Return USD Unhedged Index. Under normal market conditions, F/m Investments LLC seeks to achieve the Fund's investment objective by investing at least 80 percent of the Fund's net assets in the component securities of the Underlying Index, provided, however, that in the event that the most recently auctioned outstanding Treasury Note that matures closest to, but not beyond, 10 years from the rebalancing date is not included in the Underlying Index, then the Fund will invest at least 80 percent of its net assets in the most recently auctioned outstanding Treasury Note that matures closest to, but not beyond, 10 years from the rebalancing date. The Fund may enter into reverse repurchase agreements in amounts not exceeding one-third of the Fund's total assets.

US Treasury 10 Year Note ETF

In a significant industry shift, Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) is emerging as a formidable player in the <a href="https://www.benzinga.com/topic/artificial-intelligence">AI infrastructure arena</a>, challenging traditional perceptions of its market role. This transformation, highlighted by Scotiabank&#8217;s recent endorsement, suggests Oracle&#8217;s strategic pivot towards AI and cloud services could redefine its growth trajectory and market valuation.
Scotiabank analyst Patrick Colville initiated coverage of Oracle on Thursday, assigning a Sector Outperform rating and a <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast of $300.</a>
Colville suggests Oracle is undergoing a major transformation, evolving into a top-tier independent AI infrastructure provider.
While many investors remain cautious about its GPU-as-a-service strategy, Colville writes that Oracle Cloud Infrastructure (OCI) is set to outperform guidance in fiscal 2026, fueled by strong AI demand.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/topics/25/07/46469255/nvidia-john-kerry-and-googles-jeff-dean-back-startup-promising-the-ultimate-virtual-power-plant-to-cut-grid-stress" rel="noreferrer noopener">Nvidia, John Kerry And Google&#8217;s Jeff Dean Back Startup Promising The Ultimate Virtual Power Plant To Cut Grid Stress</a>
His analysis downplays concerns about NeoCloud&#8217;s margin impact and argues that current Street estimates are reasonable.
Colville sees Oracle as under-owned by long-only funds and believes shares could climb as the company beats expectations.
Based on conversations with Oracle customers and competitors, he highlights OCI&#8217;s pricing, performance, and security as key strengths. Oracle&#8217;s capital access, NVIDIA Corporation&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) support, and neutral stance on building foundation models give it a further edge.
He estimates Oracle&#8217;s GPU infrastructure revenue will quadruple year over year to $10 billion in fiscal 2026—assuming the Abilene AI data center launches on schedule.
Colville notes the real risk for investors may be missing out, as Oracle continues to execute amid lingering skepticism.
Colville sees Oracle&#8217;s new cloud database partnerships with Amazon, Microsoft, and Google as a pivotal step forward, helping to stabilize its declining database market share, which fell to 17% in 2024.
Based on CIO insights, the analyst expects these alliances to curb further losses and drive Oracle&#8217;s cloud database revenue to a projected $4.5 billion run rate by fiscal 2027.
While margin concerns persist among investors, Colville argues they&#8217;re exaggerated.
Though gross margins may decline with NeoCloud scaling, Oracle&#8217;s tight control over operating costs is likely to sustain strong profitability, with estimated non-GAAP operating margins of 42.4% in fiscal 2026—above consensus—and 42% in fiscal 2027.
Initiating coverage with a Sector Outperform rating, the analyst believes Oracle&#8217;s valuation premium is warranted as the company undergoes an &#8220;AI renaissance,&#8221; supported by growth expectations that outpace large-cap software peers.
ORCL Price Action: Oracle shares were up 2.90% at $248.29 at the time of publication Thursday, <a href="https://www.benzinga.com/pro/" target="_blank" rel="noreferrer noopener">according to Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46467952/us-retail-sales-june-2025-fed-trump-inflation-consumer" target="_blank" rel="noreferrer noopener">US Shoppers Keep Spending, Sending A Loud Message To Powell And Trump</a></li>
</ul>
Photo: Sundry Photography / Shutterstock.com

Equities

News

Markets

Analyst Ratings

Trading Ideas

General

NVDA

ORCL

Oracle's Nvidia‑Backed AI Push Set To Upend The Cloud

WIIM

ATLX

IONR

LITM

SGML

Shares of lithium companies are trading higher after Zangge Mining, a Chinese mining company, halted production of the commodity at a facility in Qinghai province on orders from local government officials.

FDA Advisory Panel Votes Against GSK Blood Cancer Drug Blenrep In Combination With Bortezomib And Dexamethasone In Previously Treated Patients

Encompass Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) has outperformed the market over the past 15 years by 2.16% on an annualized basis producing an average annual return of 14.44%. Currently, Encompass Health has a market capitalization of $11.09 billion. 
Buying $1000 In EHC: If an investor had bought $1000 of EHC stock 15 years ago, it would be worth $7,571.25 today based on a price of $109.92 for EHC at the time of writing.
<h3>Encompass Health's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752770711_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Encompass Health 15 Years Ago Would Be Worth Today

Lithium is trading higher after Zangge Mining, a Chinese mining company, halted production of the commodity at a facility in Qinghai province on orders from local government officials.

BofA Securities analyst Andrew Obin reiterated a Buy rating on GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) and increased the price target from <a href="https://www.benzinga.com/quote/GEV/analyst-ratings" target="_blank" rel="noreferrer noopener">$550 to $620</a>.
The analyst forecasts GE Vernova to report $11.8 billion in orders for the second quarter of 2025, 6% higher than the consensus of $11.1 billion. This performance is primarily driven by Gas Power, which includes $5.8 billion from Power, $4.9 billion from Electrification, and $1 billion from Wind.
The forecast also includes 6GW of Gas Power turbines from significant orders in global markets such as Saudi Arabia, India, and the U.S.
The expected adjusted EBITDA for the second quarter of 2025 is $0.7 billion, which aligns with Wall Street expectations. The increase in gas turbine orders is set to fuel growth in the Power and Electrification segments.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/04/44955951/ge-vernova-can-mitigate-tariff-and-inflation-concerns-after-strong-q1-sticks-to-annual-outlook" target="_blank" rel="noreferrer noopener">GE Vernova Can Mitigate Tariff And Inflation Concerns After Strong Q1, Sticks To Annual Outlook</a>
The analyst&#8217;s price target of $620 reflects increased estimates for 2027 EBITDA (+6%) and EPS (+11%). The company&#8217;s shares have surged 67% YTD, outperforming the S&amp;P 500 by a wide margin. Despite rising multiples, the analyst believes GE Vernova&#8217;s 22x multiple on 2027E EBITDA is justified due to strong earnings growth.
With tariff costs decreasing following agreements such as the May 14 deal, GE Vernova benefits from lower import duties, particularly on Chinese goods, which had previously been a major cost. Obin expects the tariff impact to be largely offset in 2025.
The analyst also points to the potential effects of the One Big Beautiful Bill Act (passed July 4), which phases out U.S. wind tax credits. This may spur an increase in U.S. onshore wind orders in the second half of 2025 and the first half of 2026, but could result in lower wind deliveries in 2027 and beyond.
Also Read: <a href="https://www.benzinga.com/markets/equities/25/07/46271577/trumps-big-beautiful-bill-slashes-solar-incentives-cathie-woods-ark-says-nuclear-may-now-be-chea" target="_blank" rel="noreferrer noopener">Trump&#8217;s Big Beautiful Bill Slashes Solar Incentives — Cathie Wood&#8217;s Ark Says Nuclear May Now Be Cheapest Option: OKLO, SMR, LTBR And Other Stocks In Focus</a>
GE Vernova will report its second-quarter 2025 financial results on July 23, 2025, before the market opening.
<a href="https://www.benzinga.com/quote/GEV/analyst-ratings">Recent Analyst Updates:</a>
<ul class="wp-block-list">
<li>JPMorgan analyst Mark Strouse maintains an Overweight rating and raised the price target from $460 to $620.</li>
<li>Citigroup analyst Andrew Kaplowitz maintains a Neutral rating and raised the price target from $354 to $544.</li>
<li>Seaport Global analyst Tom Curran initiates coverage with a Buy rating and sets a price target of $630.</li>
<li>Barclays analyst Julian Mitchell maintains an Overweight rating and increases the price target from $550 to $580.</li>
<li>BMO Capital analyst Ameet Thakkar maintains an Outperform rating and raises the price target from $522 to $590.</li>
<li>UBS analyst Amit Mehrotra initiates coverage with a Buy rating and a price target of $614.</li>
<li>Morgan Stanley analyst Andrew Percoco maintains an Overweight rating and increases the price target from $422 to $511.</li>
<li>GLJ Research analyst Austin Wang initiates coverage with a Buy rating and sets a price target of $702.</li>
</ul>
GEV Price Action: GE Vernova shares are trading higher by 1.52% at $569.71 at publication on Thursday.
Read Next: • <a href="https://www.benzinga.com/markets/earnings/25/07/46466924/ge-aerospace-lifts-2025-outlook-on-soaring-orders-profits-and-cash-flow" target="_blank" rel="noreferrer noopener">GE Aerospace Lifts 2025 Outlook On Soaring Orders, Profits, And Cash Flow</a>
Photo by T. Schneider via Shutterstock

Price Target

Topics

Movers

Analysts See Big Gains Ahead For GE Vernova, Raising Price Target To $620

Bernstein analyst Nikhil Devnani maintains Etsy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) with a Market Perform and raises the price target from $45 to $50.

ETSY

Bernstein Maintains Market Perform on Etsy, Raises Price Target to $50

Shares of Centene Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) are trading lower on Thursday, hitting a new 52-week low, as worsening news from a key competitor intensified investor fears about the profitability of government-sponsored health plans. 
What To Know: The sell-off was triggered by Elevance Health, which <a href="https://www.benzinga.com/markets/earnings/25/07/46468951/elevance-health-hit-by-medicaid-troubles-trims-outlook">reported</a> a miss on second-quarter earnings and drastically slashed its full-year profit guidance, validating the market pressures Centene itself had recently flagged.
Elevance cut its 2025 adjusted earnings forecast from over $34 per share to approximately $30, citing "elevated medical cost trends" in its Affordable Care Act (ACA) and Medicaid businesses. The company's benefit expense ratio swelled, indicating it was paying out more than expected for member medical care, a direct hit to its bottom line.
This announcement pours salt on an open wound for Centene, a company heavily focused on the ACA marketplace and Medicaid. Earlier in July, Centene's stock suffered a <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46248507/centene-cnc-stocks-historic-drop-what-investors-need-to-know">historic collapse</a> after it withdrew its own 2025 financial outlook. 
The company's decision followed an actuarial data review showing its member base was sicker and more expensive than projected, leading to an anticipated $1.8 billion reduction in risk adjustment revenue.
Elevance's guidance shock confirms that the high medical costs and risk-pricing challenges are a sector-wide crisis, not a problem isolated to Centene.
Benzinga Edge Rankings: According to <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a>, which ranks stocks based on four critical factors, Centene exhibits a distinct profile of strengths and weaknesses. The stock scores exceptionally well on Value, with a rating of 91.06, suggesting it is significantly undervalued compared to its peers or fundamental worth. 
It also shows solid Growth potential with a score of 69.56. However, these positive attributes are sharply contrasted by extremely low scores in Momentum (6.04) and Quality (5.46). 
This combination indicates that while the stock may be cheap with good growth prospects, its recent price performance has been very poor and its underlying financial health could be a concern.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, CNC shares are trading lower by 2.93% to $29.52 Thursday morning. The stock has a 52-week high of $80.59 and a 52-week low of $29.30.
Read Also: <a href="https://www.benzinga.com/news/health-care/25/07/46396470/elevance-steps-in-as-unitedhealth-delays-will-it-set-the-tone-for-insurers">Elevance Steps In As UnitedHealth Delays — Will It Set The Tone For Insurers?</a>
<h2 class="wp-block-heading">How To Buy CNC Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Centene&#8217;s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

Centene Stock Hit A New 52-Week Low Today: What's Going On?

Keybanc analyst Justin Patterson reiterated <a href="https://www.benzinga.com/quote/META/analyst-ratings" target="_blank" rel="noreferrer noopener">an Overweight rating</a> for Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and raised the price forecast from $655 to $800 on Wednesday, citing strong second-quarter ad trends, stable macro conditions, and momentum in AI.
Patterson increased his 2025 and 2026 revenue and earnings estimates for Meta, anticipating a better-than-expected performance driven by resilient ad spending, improving travel trends, and a weakening U.S. dollar. 
Also Read: <a href="https://www.benzinga.com/markets/tech/25/07/46333941/meta-has-gained-26-in-2025-can-the-rally-continue" target="_blank" rel="noreferrer noopener">Meta Has Gained 26% In 2025, Can The Rally Continue?</a>
He also highlighted strength in tariff-sensitive sectors like autos and retail, and noted that large tech firms are benefiting from a "reverse acqui-hire" trend, boosting talent acquisition.
Patterson's updated target is based on projected Q2 revenue of $45.3 billion and Q3 guidance of $46.5 billion. Despite higher capex and opex from AI investments, he remains bullish, now forecasting 2027 revenue of $244 billion and EPS of $32.01.
Price Action: META stock is trading lower by 0.22% to $701.46 at last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46463670/supermicro-launches-new-ai-servers-with-intel-xeon-6-chips" target="_blank" rel="noreferrer noopener">Supermicro Launches New AI Servers With Intel Xeon 6 Chips</a></li>
</ul>
Image: Shutterstock

Reiteration

Tech

Meta Flexes Ad Strength, Analyst Cites Travel Trends And Weak US Dollar

While two of the most outspoken figures in business and media say retirement is overrated or unnecessary, most Americans still see it as one of life's biggest goals.
<h2 class="wp-block-heading">Financially Stressful, But Emotionally Rewarding</h2>
In a recent <a href="https://x.com/GrantCardone/status/1945407404084269117">post on X</a>, billionaire investor Grant Cardone listed three reasons he'll never retire: Love for work, purpose and challenges and deadlines. He wrote, "Work gives me a sense of purpose and contribution," and "I do better when there are challenges to be resolved by some time. I like &#8216;can we do it?&#8217;"
Conservative commentator Ben Shapiro voiced similar views last year, <a href="https://x.com/benshapiro/status/1767613281596784759?lang=en">saying</a> on his podcast, "No one in the United States should be retiring at 65 years old. Frankly, I think retirement itself is a stupid idea unless you have some sort of health problem." He argued that people need purpose and added in a post on X that "If you are mentally and physically healthy, taxpayers should not pay you to retire at 65."
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – Many are rushing to grab <a href="https://www.benzinga.com/money/mode-mobile-2">4,000 of its pre-IPO shares for just $0.30/share</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
Shapiro also pointed to economics, <a href="https://x.com/benshapiro/status/1767614732108759321">writing</a>, "America will have to <a href="https://www.benzinga.com/personal-finance/25/03/44552100/i-have-no-doubt-theyre-going-to-raise-the-full-retirement-age-possibly-to-70-suze-orman-weighs-in-on-social-security-fears">raise the retirement age</a> because economics exist. Your choices are massive tax increases on the middle class (a la Europe) and raising the retirement age. There is no third choice."
<h2 class="wp-block-heading">Most Americans Still Want to Retire</h2>
But the majority of Americans don't share Cardone and Shapiro's stance. According to a 2024 <a href="https://www.wealthenhancement.com/blog/retirement-survey-are-americans-ready-for-retirement-see-how-you-compare">survey</a> by Wealth Enhancement Group, 77% of U.S. adults say they feel happy or grateful when thinking about retirement. Among those already retired, 90% said they didn't regret it, and 33% said it was even better than expected.
Despite that optimism, the financial side of retirement is a major concern. More than half of Americans who haven&#8217;t retired yet say <a href="https://www.benzinga.com/economics/24/07/39648173/how-does-inflation-impact-retirement">inflation</a> has delayed their goals by an average of eight years or more. About 80% doubt they'll have enough money to fund their ideal retirement.
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
Confidence varies by generation. Millennials are the most optimistic, with 37% saying they're on track and 5% saying they've already hit their goals. Gen Xers, on the other hand, are the least prepared, with 25% saying they <a href="https://www.benzinga.com/25/05/45609421/i-am-just-done-gen-x-er-wants-to-retire-at-55-but-has-no-money-saved-in-a-single-income-household-why-does-everyt">haven't set any retirement goals</a>.
Still, Americans aren't giving up. In the survey, a majority say they're taking steps to improve their finances, such as saving more money monthly and <a href="https://www.benzinga.com/money/how-to-create-a-budget">keeping a budget</a>. Retirees who planned ahead are more likely to include things like philanthropy, estate planning, and long-term care in their financial strategies.
What do people want most from retirement? Travel, hobbies, relaxation, and time with family. While Gen Z and Gen X prioritize travel, millennials value family time, and boomers want to rest.
Even with the challenges, retirement remains a defining goal for most. As Wealth Enhancement's Ayako Yoshioka put it, "When considering your golden years, a good plan centers on what you want out of life. First comes the vision, then come the numbers."
Read Next:
<ul class="wp-block-list">
<li>This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Grant Cardone And Ben Shapiro Don't Believe In Retirement, But For Most Americans, It's Still The Dream And Not 'A Stupid Idea'

MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) has outperformed the market over the past 5 years by 4.74% on an annualized basis producing an average annual return of 18.79%. Currently, MercadoLibre has a market capitalization of $121.95 billion. 
Buying $100 In MELI: If an investor had bought $100 of MELI stock 5 years ago, it would be worth $235.15 today based on a price of $2405.44 for MELI at the time of writing.
<h3>MercadoLibre's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752769815_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MELI

Here's How Much You Would Have Made Owning MercadoLibre Stock In The Last 5 Years

Editor's note: The article and headline have been corrected to clarify Chamath Palihapitiya's SPAC involvement and update the price performance.
Three SPAC‑listed companies—SoFi Technologies Inc. (NASDAQ: SOFI) and Opendoor Technologies Inc. (NASDAQ: OPEN), both taken public via <a href="https://www.benzinga.com/topic/chamath-palihapitiya">Chamath Palihapitiya</a>–sponsored vehicles, and MP Materials Corp. (NYSE: MP), which merged with Fortress Value Acquisition Corp. in a deal anchored by a PIPE that included Palihapitiya—are staging an unexpected comeback in 2025, posting year‑to‑date returns that outpace even tech giant Nvidia Corp. (NASDAQ: NVDA). <a href="https://mpmaterials.com/news//press-release-11-17-2020/?utm_source=chatgpt.com" target="_blank" rel="noreferrer noopener"></a>
<h2 class="wp-block-heading">Surging Stock Performance</h2>
While Nvidia remains a headline grabber with a monthly gain of roughly 20%, Chamath's SPAC trio has quietly delivered impressive returns. Opendoor ($OPEN) leads the pack, rallying around 190% over the past month, followed by MP Materials ($MP) at 65% and SoFi ($SOFI) up about 52%.
This resurgence marks a significant turnaround after years of skepticism surrounding SPACs.
Read Also: <a href="https://www.benzinga.com/markets/equities/25/06/46012786/chamath-palihapitiya-asks-if-he-should-launch-another-spac-70-say-no-users-warn-of-past-failures-no-crying-in-the-casino">Chamath Palihapitiya Asks If He Should Launch Another SPAC—70% Say No, Users Warn of Past Failures: &#8216;No Crying In The Casino!&#8217;</a>
<h2 class="wp-block-heading">Why The Revival?</h2>
These stocks have shaken off their "SPAC stigma" by showing improving fundamentals and strategic pivots. 
<ul class="wp-block-list">
<li>SoFi, initially a fintech darling, has broadened its offerings and grown its user base. </li>
<li>MP Materials, a company specializing in rare-earth materials, benefits from increased demand amid supply chain and geopolitical tensions.</li>
<li>Opendoor, despite some headwinds, has optimized its operations and is riding a recovering real estate market.</li>
</ul>
<h2 class="wp-block-heading">What About $SPCE?</h2>
Investors are now closely watching&nbsp;Virgin Galactic Holdings Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>), the original space-focused SPAC, to see if it can join this rally.
While SPCE&#8217;s 29% gain over the past month pales in comparison to other SPACs, it still manages to outshine Nvidia. The momentum in Chamath's SPACs raises questions about whether a broader "Chamath revival" is underway or if these gains are isolated.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46337678/chamath-palihapitiya-agrees-with-a-social-media-user-who-says-while-meta-spends-200-million-a-year-to-poach-ai-talent-elon-musk-keeps-costs-low-but-still-manages-to-unveil-better-products">Chamath Palihapitiya Agrees With A Social Media User Who Says While Meta Spends $200 Million A Year To Poach AI Talent, Elon Musk Keeps Costs Low But Still Manages To Unveil Better Products</a></li>
</ul>
Photo: Shutterstock

OPEN

SOFI

SPCE

Chamath‑Connected SPAC Listings Are Crushing Nvidia — Wall Street Didn't See This Coming (CORRECTED)

MDLZ

Mondelez International is trading higher after Jefferies upgraded the stock from hold to buy and raised its price target from $66 to $78.

Shares of auto retail ecosystem companies have outperformed year-to-date, despite the announcement of auto tariffs and industry fundamentals weakening "even before the impact of tariffs have flowed through to vehicle pricing," according to JPMorgan.
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e68c15a5f2b9b0001143528/rajat-gupta">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e68c15a5f2b9b0001143528/rajat-gupta">Rajat Gupta</a> changed ratings on these four stocks.
<h1 class="wp-block-heading">Cars.com</h1>
JPMorgan upgraded the rating for Cars.com Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARS#NYSE">CARS</a>) from Neutral to Overweight, while establishing a price target of $14.
Shares of companies in the business-to-consumer)marketplaces have underperformed franchise dealers so far this year, Gupta said. Although B2C marketplaces are not immune to broader industry pressures, they are better positioned than business-to-business marketplaces, he added.
Cars.com has taken "significant strides in developing new products and solutions that integrate them into dealers' operational workflows, including market intelligence, consumer sourcing functionalities, D2D wholesale, and online retailing, which bodes well for the retention of dealer customers, even amid a volatile industry backdrop," he further wrote.
<h1 class="wp-block-heading">Sonic Automotive</h1>
The analyst downgraded Sonic Automotive Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>) from Overweight to Underweight, while raising the price target from $65 to $72.
While Sonic Automotive boasts a "strong luxury brand mix and exposure to California and Texas," the company has underperformed its peers, the analyst stated. Its stock currently trades at a premium to peers, "despite macro and industry headwinds and elevated balance sheet leverage," he added. &nbsp;
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">Group 1 Automotive</h1>
JPMorgan downgraded Group 1 Automotive Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPI#NYSE">GPI</a>) from Overweight to Neutral, while reducing the price target from $435 to $415.
The company's execution has been solid for several years, "with favorable Texas exposure serving as a relative tailwind," Gupta said. He added, however, that concentration in one state makes for increased volatility, "as regional economic conditions could significantly impact growth."
<h1 class="wp-block-heading">Asbury Automotive Group</h1>
Gupta downgraded Asbury Automotive Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABG#NYSE">ABG</a>) from Neutral to Underweight, while cutting the price target from $235 to $225.
"While Asbury's strategic acquisitions, expansion into captive warranty, and digital investments like Clicklane position it for long-term growth, JPMorgan sees the risk-reward as unfavorable due to integration and execution risks, elevated leverage, and underperformance in used vehicle gross profit since 2019," the analyst wrote.
CARS, SAH, GPI, ABG Price Action: At the time of publication on Thursday,
<ul class="wp-block-list">
<li>Shares of Cars.com had risen by 4.54% to $12.89.</li>
<li>Sonic Automotive's stock had declined by 8.79% to $77.68.</li>
<li>Group 1 Automotive's share price had declined by 7.36% to $411.80.</li>
<li>Shares of Asbury Automotive had declined by 5.72% to $233.98.</li>
</ul>
Read More:<a href="https://www.benzinga.com/markets/equities/25/06/46111337/micron-ceo-cautions-ai-boom-may-not-be-fully-sustainable-flags-tariff-driven-demand-pull-in"> </a> • <a href="https://www.benzinga.com/markets/equities/25/06/46111337/micron-ceo-cautions-ai-boom-may-not-be-fully-sustainable-flags-tariff-driven-demand-pull-in">Inventory Stabilizes, But Cars.com Lags Peers: Analyst Flags Profit Pressures</a>

Photo: Shutterstock

CARS

Analyst Revs Up Cars.com, Hits The Brakes On 3 Others

CTAS

Cintas is trading higher after the company reported better-than-expected Q4 EPS and sales.

Editor&#8217;s Note: The title of the story has been corrected to reflect that the outlook was raised, instead of the erroneous &#8220;outlook cut&#8221; mentioned in the original title.
Swiss pharmaceutical giant Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) reported second-quarter 2025 earnings on Thursday and raised its full-year earnings forecast.
Quarterly sales reached $14.05 billion, almost in line with the analysts&#8217; consensus <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">estimate of $14.06 billion</a>.
Net sales <a target="_blank" href="https://www.novartis.com/news/media-releases/novartis-reports-strong-q2-double-digit-sales-growth-and-core-margin-expansion-raises-fy-2025-core-operating-income-guidance" rel="noreferrer noopener">grew</a> 12% year over year (+11% on constant currency or cc) with core operating income up 20% to $5.93 billion (+21% on constant currency).
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/07/46292859/novartis-gets-swiss-approval-for-first-malaria-drug-for-babies" rel="noreferrer noopener">Novartis Gets Swiss Approval For First Malaria Drug For Babies</a>
Sales growth driven by performance from breast cancer treatment, Kisqali ($1.18 billion, +64% cc), Entresto ($2.36 billion, +22% cc), multiple sclerosis drug, Kesimpta ($1.08 billion, +33% cc), Scemblix ($298 million, +79% cc), Leqvio ($298 million, +61% cc), and Pluvicto ($454 million, +30% cc).
Novartis reported adjusted earnings of $2.42 per share, beating the consensus of $2.38.
The company also announced a substantial share buyback program. Novartis said it is initiating a share buyback of up $10 billion to be completed by year-end 2027.
&#8220;Our robust balance sheet and confidence in our mid- and long-term growth enable us to initiate an up-to $10 billion share buyback as part of our commitment to balanced capital allocation,&#8221; stated CEO Vas Narasimhan in a statement on Thursday.
Earlier in July, Novartis released topline results from the Phase 3 GCAptAIN study evaluating Cosentyx (secukinumab) for newly diagnosed or relapsing <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">giant cell arteritis (GCA)</a>.
The study evaluated Cosentyx with a 26-week steroid taper and compared it to a placebo plus a 52-week steroid taper.&nbsp;Cosentyx did not demonstrate a statistically significant improvement in sustained remission at <a target="_blank" href="https://www.benzinga.com/news/health-care/25/07/46243947/novartis-cosentyx-fails-late-stage-giant-cell-arteritis-trial" rel="noreferrer noopener">Week 52 compared to placebo</a>.
<h2 class="wp-block-heading">Outlook</h2>
For fiscal year 2025, Novartis reaffirms that net sales will grow in the high single digits. 2025 core operating income is expected to grow in the low teens, compared to the low double <a target="_blank" href="https://www.benzinga.com/25/04/45075714/novartis-q1-earnings-beat-street-view-ceo-confident-to-deliver-upgraded-2025-guidance" rel="noreferrer noopener">digits forecasted earlier</a>.
&#8220;We continue to assume Entresto US generic entry in mid-2025 for forecasting purposes, though the timing of generic entry is subject to ongoing IP and regulatory litigation,&#8221; Novartis said in the release.
<h2 class="wp-block-heading">Management Update</h2>
In a separate announcement, Novartis provided a key leadership update: Chief Financial Officer Harry Kirsch will <a target="_blank" href="https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company" rel="noreferrer noopener">retire</a> in March 2026, concluding an impressive 22-year tenure at the company, including 12 years in the CFO role since 2013.
He will be succeeded by Mukul Mehta, who currently serves as the company&#8217;s head of business planning and analysis, digital finance, and tax.
Price Action: NVS stock is trading lower by 1.71% to $116.35 during the premarket session at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46463670/supermicro-launches-new-ai-servers-with-intel-xeon-6-chips" target="_blank" rel="noreferrer noopener">Supermicro Launches New AI Servers With Intel Xeon 6 Chips</a></li>
</ul>
Photo via Shutterstock

Biotech

Earnings

Large Cap

Guidance

Health Care

Buybacks

Management

Novartis Raises Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback (CORRECTED)

Unity Software shares are trading higher after UBS raised its price target on the stock from $22 to $33. Also, Wedbush raised its price target on the stock from $31.5 to $39.

The Trade Desk shares are trading higher after multiple analysts raised their price targets on the stock.

Primerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) has outperformed the market over the past 10 years by 8.02% on an annualized basis producing an average annual return of 19.51%. Currently, Primerica has a market capitalization of $8.63 billion. 
Buying $1000 In PRI: If an investor had bought $1000 of PRI stock 10 years ago, it would be worth $5,885.71 today based on a price of $262.59 for PRI at the time of writing.
<h3>Primerica's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752768911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Primerica 10 Years Ago Would Be Worth Today

Webull Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) shares are trading higher Thursday after the company announced it will reintroduce crypto trading to its global customer base and integrate Webull Pay back <a href="https://www.benzinga.com/node/46465772">into Webull Group.</a>
What To Know: Webull said it will consolidate Webull Pay into the broader Webull Group as part of a business combination approved by both companies&#8217; boards and shareholders. The move positions Webull to roll out crypto trading in the United States through its app in the third quarter.
The company cited improved regulatory clarity as a key driver of its decision and said crypto trading is already live in Brazil, with more market expansions planned later this year.
How To Buy Webull Stock
By now you're likely curious about how to participate in the market for Webull (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Webull, which is trading at $13.70 as of publishing time, $100 would buy you 7.3 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
See Also: <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46466501/interactive-brokers-earnings-are-imminent-these-most-accurate-analysts-revise-">Interactive Brokers Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>
BULL Price Action: At the time of publication, Webull stock is trading 6.2% higher at $13.70, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Image via Shutterstock

Comments

US Treasury 10 Year Note ETF

Interés en corto

US Treasury 10 Year Note ETF (NASDAQ:UTEN), Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL